Search

Michal M Margalith

from Solana Beach, CA
Age ~84
Get Report
Also known as:
Michael Margalith
Phone and address:
434 Santa Cecelia, Solana Beach, CA 92075
(858) 259-0427
Related to:
Yin Liu, 62Tanchin LiuHuiwen ChungZachary J Dickinson, 43Dee Wen-Yin, 67
Connected to:
Nicholas G Margalis, 39Ofer Margalit, 41Rui M Margalho, 75Eduardo U Margallo, 69Sevana S Marganian, 31Vacheh A Marganian, 54Danielle P Marganoff, 40Adam A Marganski, 71Alison J Marganski, 41Debra L Marganski, 63

Michal Margalith Phones & Addresses

  • 434 Santa Cecelia, Solana Beach, CA 92075 (858) 259-0427 (858) 259-8727
  • Santa Barbara, CA
  • San Diego, CA
  • Seattle, WA
  • 434 Santa Cecelia, Solana Beach, CA 92075 (858) 752-8368

Work

Position: Retired

Education

Degree: Associate degree or higher

Publications

Us Patents

Cancer Treatment Method Utilizing Plasmids Suitable For Il-2 Expression

View page
US Patent:
6399588, Jun 4, 2002
Filed:
Jul 28, 2000
Appl. No.:
09/628445
Inventors:
Peter M. Hobart - Poway CA
Michal Margalith - Solana Beach CA
Suezanne E. Parker - San Diego CA
Shirin Khatibi - Carlsbad CA
Assignee:
Vical Incorporated - San Diego CA
International Classification:
C07H 2104
US Classification:
514 44, 536 2352, 4353201
Abstract:
The present invention relates to plasmids suitable for IL-2 expression, particularly, human IL-2 expression, and related methods.

Compositions And Methods For Vaccinating Against Hsv-2

View page
US Patent:
7628993, Dec 8, 2009
Filed:
Jul 20, 2007
Appl. No.:
11/781153
Inventors:
Adrian Vilalta - San Diego CA, US
Michal Margalith - Solana Beach CA, US
Lichun Dong - Seattle WA, US
David M. Koelle - Seattle WA, US
Assignee:
Vical Incorporated - San Diego CA
University of Washington - Seattle WA
International Classification:
A61K 39/245
US Classification:
4242311, 435 6
Abstract:
This invention relates to a method for systemic immune activation which is effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in a mammal. The method is particularly effective for protecting a mammal from herpes simplex virus. Also disclosed are therapeutic compositions useful in such a method.

Compositions And Methods For Vaccinating Against Hsv-2

View page
US Patent:
7879339, Feb 1, 2011
Filed:
Oct 16, 2009
Appl. No.:
12/580908
Inventors:
Adrian Vilalta - San Diego CA, US
Michal Margalith - Solana Beach CA, US
Lichun Dong - Seattle WA, US
David Koelle - Seattle WA, US
Assignee:
Vical Incorporated - San Diego CA
The University of Washington - Seattle WA
International Classification:
A61K 39/245
US Classification:
4242311, 435 6
Abstract:
This invention relates to a method for systemic immune activation which is effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in a mammal. The method is particularly effective for protecting a mammal from herpes simplex virus. Also disclosed are therapeutic compositions useful in such a method.

Compositions And Methods For Vaccinating Against Hsv-2

View page
US Patent:
7935352, May 3, 2011
Filed:
Oct 16, 2009
Appl. No.:
12/581025
Inventors:
Adrian Vilalta - San Diego CA, US
Michal Margalith - Solana Beach CA, US
Lichun Dong - Seattle WA, US
David Koelle - Seattle WA, US
Assignee:
Vical Incorporated - San Diego CA
The University of Washington - Seattle WA
International Classification:
A61K 39/245
US Classification:
4242311, 435 6, 435 911
Abstract:
This invention relates to a method for systemic immune activation which is effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in a mammal. The method is particularly effective for protecting a mammal from herpes simplex virus. Also disclosed are therapeutic compositions useful in such a method.

Compositions And Methods For Vaccinating Against Hsv-2

View page
US Patent:
8263087, Sep 11, 2012
Filed:
Oct 23, 2009
Appl. No.:
12/604694
Inventors:
Adrian Vilalta - San Diego CA, US
Michal Margalith - Solana Beach CA, US
Lichun Dong - Seattle WA, US
David M. Koelle - Seattle WA, US
Assignee:
Vical Incorporated - San Diego CA
The University of Washington - Seattle WA
International Classification:
A61K 39/245
US Classification:
4242311, 4242041, 435 911
Abstract:
This invention relates to a method for systemic immune activation which is effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in a mammal. The method is particularly effective for protecting a mammal from herpes simplex virus. Also disclosed are therapeutic compositions useful in such a method.

Compositions And Methods For Vaccinating Against Hsv-2

View page
US Patent:
8293248, Oct 23, 2012
Filed:
Oct 16, 2009
Appl. No.:
12/581058
Inventors:
Adrian Vilalta - San Diego CA, US
Michal Margalith - Solana Beach CA, US
Lichun Dong - Seattle WA, US
David Koelle - Seattle WA, US
Assignee:
Vical Incorporated - San Diego CA
The University of Washington - Seattle WA
International Classification:
A61K 39/245
US Classification:
4242311, 435 5
Abstract:
This invention relates to a method for systemic immune activation which is effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in a mammal. The method is particularly effective for protecting a mammal from herpes simplex virus. Also disclosed are therapeutic compositions useful in such a method.

Plasmids Suitable For Il-2 Expression

View page
US Patent:
20030203863, Oct 30, 2003
Filed:
Apr 23, 2002
Appl. No.:
10/127683
Inventors:
Peter Hobart - Poway CA, US
Michal Margalith - Solana Beach CA, US
Suezanne Parker - San Diego CA, US
Shirin Khatibi - Carlsbad CA, US
Assignee:
Vical Incorporated
International Classification:
A61K048/00
C12P021/04
C12P021/02
C12N005/08
C12N015/85
US Classification:
514/044000, 435/320100, 435/069520, 435/366000, 435/455000
Abstract:
The present invention relates to plasmids suitable for IL-2 expression, particularly, human IL-2 expression, and related methods.

Plasmids Suitable For Il-2 Expression

View page
US Patent:
20050065107, Mar 24, 2005
Filed:
Oct 15, 2004
Appl. No.:
10/965238
Inventors:
Peter Hobart - Poway CA, US
Michal Margalith - Solana Beach CA, US
Suezanne Parker - San Diego CA, US
Shirin Khatibi - Carlsbad CA, US
International Classification:
A61K048/00
US Classification:
514044000, 435320100
Abstract:
The present invention relates to plasmids suitable for IL-2 expression, particularly, human IL-2 expression, and related methods.
Control profile
Michal M Margalith from Solana Beach, CA, age ~84 Get Report